135 related articles for article (PubMed ID: 34289045)
21. Therapy of visceral leishmaniasis due to Leishmania infantum: experimental assessment of efficacy of AmBisome.
Gangneux JP; Sulahian A; Garin YJ; Farinotti R; Derouin F
Antimicrob Agents Chemother; 1996 May; 40(5):1214-8. PubMed ID: 8723469
[TBL] [Abstract][Full Text] [Related]
22. Ex vivo host and parasite response to antileishmanial drugs and immunomodulators.
Gonzalez-Fajardo L; Fernández OL; McMahon-Pratt D; Saravia NG
PLoS Negl Trop Dis; 2015 May; 9(5):e0003820. PubMed ID: 26024228
[TBL] [Abstract][Full Text] [Related]
23. Association of water extract of green propolis and liposomal meglumine antimoniate in the treatment of experimental visceral leishmaniasis.
Ferreira FM; Castro RA; Batista MA; Rossi FM; Silveira-Lemos D; Frézard F; Moura SA; Rezende SA
Parasitol Res; 2014 Feb; 113(2):533-43. PubMed ID: 24292604
[TBL] [Abstract][Full Text] [Related]
24. A trial of immunotherapy against Leishmania amazonensis infection in vitro and in vivo with Z-100, a polysaccharide obtained from Mycobacterium tuberculosis, alone or combined with meglumine antimoniate.
Barroso PA; Marco JD; Calvopina M; Kato H; Korenaga M; Hashiguchi Y
J Antimicrob Chemother; 2007 Jun; 59(6):1123-9. PubMed ID: 17439977
[TBL] [Abstract][Full Text] [Related]
25. Comparative efficacy of meglumine antimoniate and aminosidine sulphate, alone or in combination, in canine leishmaniasis.
Oliva G; Gradoni L; Cortese L; Orsini S; Ciaramella P; Scalone A; de Luna R; Persechino A
Ann Trop Med Parasitol; 1998 Mar; 92(2):165-71. PubMed ID: 9625912
[TBL] [Abstract][Full Text] [Related]
26. Meglumine Antimoniate-Loaded Aqueous-Core PLA Nanocapsules: Old Drug, New Formulation against Leishmania-Related Diseases.
Cosco D; Bruno F; Castelli G; Puleio R; Bonacci S; Procopio A; Britti D; Fresta M; Vitale F; Paolino D
Macromol Biosci; 2021 Jul; 21(7):e2100046. PubMed ID: 34117834
[TBL] [Abstract][Full Text] [Related]
27. Antimony resistance associated with persistence of Leishmania (Leishmania) infantum infection in macrophages.
Magalhães LS; Bomfim LGS; Santos CNO; Dos Santos PL; Tanajura DM; Lipscomb MW; de Jesus AR; de Almeida RP; de Moura TR
Parasitol Res; 2021 Aug; 120(8):2959-2964. PubMed ID: 34272999
[TBL] [Abstract][Full Text] [Related]
28. Decreased antimony uptake and overexpression of genes of thiol metabolism are associated with drug resistance in a canine isolate of Leishmania infantum.
Gómez Pérez V; García-Hernandez R; Corpas-López V; Tomás AM; Martín-Sanchez J; Castanys S; Gamarro F
Int J Parasitol Drugs Drug Resist; 2016 Aug; 6(2):133-9. PubMed ID: 27317865
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of meglumine antimoniate after administration of a multiple dose in dogs experimentally infected with Leishmania infantum.
Valladares JE; Riera C; Alberola J; Gállego M; Portús M; Cristòfol C; Franquelo C; Arboix M
Vet Parasitol; 1998 Feb; 75(1):33-40. PubMed ID: 9566092
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic effect of reference antileishmanial agents in murine visceral leishmaniasis due to Leishmania infantum.
Buffet PA; Garin YJ; Sulahian A; Nassar N; Derouin F
Ann Trop Med Parasitol; 1996 Jun; 90(3):295-302. PubMed ID: 8758143
[TBL] [Abstract][Full Text] [Related]
31. Experimental evaluation of second-line oral treatments of visceral leishmaniasis caused by Leishmania infantum.
Gangneux JP; Dullin M; Sulahian A; Garin YJ; Derouin F
Antimicrob Agents Chemother; 1999 Jan; 43(1):172-4. PubMed ID: 9869587
[TBL] [Abstract][Full Text] [Related]
32. Biodistribution of meglumine antimoniate in healthy and Leishmania (Leishmania) infantum chagasi-infected BALB/c mice.
Borborema SE; Osso JA; Andrade HF; Nascimento Nd
Mem Inst Oswaldo Cruz; 2013 Aug; 108(5):623-30. PubMed ID: 23903979
[TBL] [Abstract][Full Text] [Related]
33. In vitro evaluation of the effectiveness and cytotoxicity of meglumine antimoniate microspheres produced by spray drying against Leishmania infantum.
Pujals G; Suñé-Negre JM; Pérez P; García E; Portus M; Tico JR; Miñarro M; Carrió J
Parasitol Res; 2008 May; 102(6):1243-7. PubMed ID: 18278586
[TBL] [Abstract][Full Text] [Related]
34. Long-term follow-up of dogs with leishmaniosis treated with meglumine antimoniate plus allopurinol versus miltefosine plus allopurinol.
Manna L; Corso R; Galiero G; Cerrone A; Muzj P; Gravino AE
Parasit Vectors; 2015 May; 8():289. PubMed ID: 26017164
[TBL] [Abstract][Full Text] [Related]
35. In vitro drug susceptibility of Leishmania infantum isolated from humans and dogs.
Maia C; Nunes M; Marques M; Henriques S; Rolão N; Campino L
Exp Parasitol; 2013 Sep; 135(1):36-41. PubMed ID: 23747751
[TBL] [Abstract][Full Text] [Related]
36. Leishmania infantum exerts immunomodulation in canine Kupffer cells reverted by meglumine antimoniate.
Rodrigues A; Santos-Mateus D; Alexandre-Pires G; Valério-Bolas A; Rafael-Fernandes M; Pereira MA; Ligeiro D; de Jesus J; Alves-Azevedo R; Lopes-Ventura S; Santos M; Tomás AM; Pereira da Fonseca I; Santos-Gomes G
Comp Immunol Microbiol Infect Dis; 2017 Dec; 55():42-52. PubMed ID: 29127992
[TBL] [Abstract][Full Text] [Related]
37. Novel methods for the encapsulation of meglumine antimoniate into liposomes.
Frézard F; Michalick MS; Soares CF; Demicheli C
Braz J Med Biol Res; 2000 Jul; 33(7):841-6. PubMed ID: 10881061
[TBL] [Abstract][Full Text] [Related]
38. Leishmania infantum infection rates in Phlebotomus perniciosus fed on naturally infected dogs under antimonial treatment.
Gradoni L; Maroli M; Gramiccia M; Mancianti F
Med Vet Entomol; 1987 Oct; 1(4):339-42. PubMed ID: 2979550
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of polymorphonuclear cell and monocyte functions in Leishmania infantum-infected dogs.
Brandonisio O; Panunzio M; Faliero SM; Ceci L; Fasanella A; Puccini V
Vet Immunol Immunopathol; 1996 Sep; 53(1-2):95-103. PubMed ID: 8941972
[TBL] [Abstract][Full Text] [Related]
40. DH82 Canine and RAW264.7 Murine Macrophage Cell Lines Display Distinct Activation Profiles Upon Interaction With
Nadaes NR; Silva da Costa L; Santana RC; LaRocque-de-Freitas IF; Vivarini ÁC; Soares DC; Wardini AB; Gazos Lopes U; Saraiva EM; Freire-de-Lima CG; Decote-Ricardo D; Pinto-da-Silva LH
Front Cell Infect Microbiol; 2020; 10():247. PubMed ID: 32596164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]